Lusayan, Peah P.

HRN: 22-40-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/22/2023
10/22/2023
IV
4.5g Loading Dose
Now
Sepsis
Waiting Final Action 
10/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/22/2023
10/29/2023
IV
2.25g
Q6
Sepsis
Waiting Final Action 
10/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/23/2023
11/02/2023
IV
4.5gms
Q8
Sep
Waiting Final Action 
10/27/2023
MUPIROCIN 2%, 15G (TUBE)
10/27/2023
10/31/2023
TOPICAL
Apply Thinly
BIDA
Post Op Site Infection
Waiting Final Action 
11/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/01/2023
11/07/2023
IVTT
500 Mg
Q6
Acute Appendicitis S/p Appendectomy; Sepsis
Waiting Final Action 
11/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/01/2023
11/07/2023
IVT
4.5gms
Q6
Sepsis
Waiting Final Action 
11/02/2023
CEFTAZIDIME 1GM (VIAL)
11/02/2023
11/08/2023
IVT
2gms
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: